Chai Biotechnologies
PrivateLast Round
Strategic
Jan 4, 2024
Est. Valuation
$450M
Total Funding Raised
$2M
Company Overview
Chai Biotechnologies operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Strategic round in January 2024.
Chai Biotechnologies is a biotechnology company that develops and manufactures real-time PCR (qPCR) instruments and diagnostics to make molecular biology research more accessible.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chai Biotechnologies Comparables
Compare Chai Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bio Molecular Systems | 79% | |
| Ubiquitome | 78% | |
| Biomeme | 78% |
For institutional investors. Book with your work email.
Chai Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 4, 2024 | ||||
| Seed | Aug 14, 2023 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2025
Grew 105% QoQ, from 37 to 76 employees.
- Jan 15, 2025
Grew 108% QoQ, from 37 to 77 employees.
For institutional investors. Book with your work email.
Chai Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chai Biotechnologies's valuation, stock price, and market status.
Is Chai Biotechnologies a public or private company?
Chai Biotechnologies is a private company.
What is the current stock price of Chai Biotechnologies?
Chai Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Chai Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chai Biotechnologies worth (valuation)?
Chai Biotechnologies's valuation is estimated at $450.0M based on funding round data.
Can I buy Chai Biotechnologies stock?
Chai Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chai Biotechnologies's last funding round?
Chai Biotechnologies's most recent funding round was Strategic on January 4, 2024.
Who are the main investors in Chai Biotechnologies?
Investor information for Chai Biotechnologies is not publicly disclosed.
Will Chai Biotechnologies IPO soon?
No public IPO plans have been announced for Chai Biotechnologies.
How can I track Chai Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Chai Biotechnologies's shares on secondary markets.